EA
Eventide Asset Management, LLC disclosed a 5.1% stake in ENGN
Eventide Asset Management, LLC reported owning 5.1% of enGene Therapeutics Inc. (ENGN) (3,406,023 shares) in a Schedule 13G filed Nov 13, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 13, 2026
- Source
- Schedule 13G